Lifestance Health Group, INC Form 4 insider transactions

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Kevin Michael Mullins, Chief Development Officer of LifeStance Health Group, sold 9,688 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Paula Cipollone, a Business Transformation Officer at LifeStance Health Group, sold 3,369 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

LifeStance Health Group's CEO, Kenneth A. Burdick, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Kevin Michael Mullins, Chief Development Officer of LifeStance Health Group, sold 44,540 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Ryan Pardo, Chief Legal Officer and Secretary of LifeStance Health Group, sold 39,384 shares of common stock on March 14, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Danish J. Qureshi, President and COO of LifeStance Health Group, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Pablo Pantaleoni, Chief Digital Officer of LifeStance Health Group, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Ujjwal Ramtekkar, Chief Medical Officer of LifeStance Health Group, acquired 62,413 restricted stock units on March 8, 2024.

Kevin Michael Mullins, Chief Development Officer of LifeStance Health Group, reports the acquisition of common stock and restricted stock units.

LifeStance Health Group's Chief Legal Officer, Ryan Pardo, reports the acquisition of common stock and vesting of performance-based restricted stock units.

Paula Cipollone, a Business Transformation Officer at LifeStance Health Group, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Ann Varanakis, Chief People Officer of LifeStance Health Group, reports acquisition and disposal of company stock to cover tax obligations related to vesting of restricted stock units.

LifeStance Health Group's CEO, Kenneth Burdick, reports acquiring common stock and vesting of restricted stock units, increasing his beneficial ownership.

Chief Digital Officer of LifeStance Health Group, Pablo Pantaleoni, reports acquiring shares through the vesting of restricted stock units.

Danish J. Qureshi, President and COO of LifeStance Health Group, acquired shares through the vesting of restricted stock units and performance-based restricted stock units.

David Bourdon, CFO of LifeStance Health Group, reports acquisition and disposal of common stock related to vesting of restricted stock units and subsequent sale to cover tax obligations.

Kevin Michael Mullins, Chief Development Officer of LifeStance Health Group, sold 115,136 shares of common stock at an average price of $8.02 on March 1, 2024, under a pre-arranged trading plan.